The listing below shows our latest News Items and is updated regularly. If you wish to post a news item please select the 'Post News' button on the right. The displayed news feed starts on 1st August 2016. Older items can be found here.
To 'Post Your News' use the button at the top right.
We are pleased to present below all posts archived in 'January 2021'. If you still can't find what you are looking for, try using the search box.
tranScrip is delighted to announce a significant minority investment from Palatine Private Equity Impact Fund, which complements the existing investment of tranScrip’s own Partners. The deal is a landmark for tranScrip, underpinning its growth as a leading specialist service provider.
Read the rest of entry »
Oxford Biomedica plc, a leading gene and cell therapy group, announced on 18 January that the Prime Minister Rt Hon Boris Johnson MP, has formally opened Oxford Biomedica’s new 84,000 sq ft manufacturing facility Oxbox based in Oxford, UK.
Researchers in the UK and the United States have succeeded in ‘fine tuning’ a new thermoplastic biomaterial to enable both the rate at which it degrades in the body and its mechanical properties to be controlled independently.
BioCity, the pioneering life science incubator and business collective, Innovate UK, NIHR and NHS England and NHS Improvement’s SBRI Healthcare programme, today announced a new partnership to support early-stage life science ventures within the UK to get investment ready.
The Hub building which will house The Rosalind Franklin Institute on the Harwell Science and Innovation Campus has reached practical completion, with the construction company Mace handing legal ownership to UK Research and Innovation. The Franklin will now commence specialist scientific fit out.
The Franklin, funded through UK Research and Innovation’s Engineering and Physical Sciences Research Council, is dedicated to creating technologies which will change the way researchers see life. These technologies will be housed in the Hub at Harwell alongside 200 researchers, including collaborators from academia and industry.
Domainex Ltd., a leading provider of integrated drug discovery services, is pleased to welcome David Cronk, CBiol, MRSB, to the team as its new Chief of Staff. The Company has also promoted long standing team member and previous Head of Chemistry, Dr Ray Boffey, to Executive Director of Medicines Research. Following a successful period of growth and expansion of its research team, both David and Ray bring a wealth of drug discovery experience and will further support Domainex’s ongoing growth plans.
On 3rd February, RSSL's Daniel Nicolau will be speaking at a complimentary webinar considering the challenges of method development for nitrosamine analysis and the risk nitrosamines can pose.
Immunocore, a late-stage biotechnology company pioneering the development of a novel class of T cell receptor (TCR) bispecific immunotherapies designed to treat a broad range of diseases, including cancer, infectious and autoimmune disease, today announced the completion of a $75.0 million Series C private financing round.
Inivata, a leader in liquid biopsy, today announces that the first patients have been tested using InVisionFirst®-Lung as part of the Phase II ALKALINE trial sponsored by the European Organisation for Research and Treatment of Cancer (EORTC). As part of the study Inivata’s InVisionFirst-Lung liquid biopsy will be used to test and monitor ALK positive non-small cell lung cancer (NSCLC) patients initiating treatment with lorlatinib, Pfizer Inc.’s third generation ALK inhibitor therapy.
The cfPure® Cell Free DNA Extraction Kit from AMSBIO is a magnetic bead-based DNA extraction kit designed to isolate circulating cell free DNA (cfDNA) from human plasma or serum samples.
OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.